Skip to main content
SpringerLink
Log in

Adiponectin inhibits mouse mammary tumor growth and reduced tumor-induced hematopoiesis

  • Original Article
  • Published:
Tissue Engineering and Regenerative Medicine Aims and scope

Abstract

Adiponectin, one of the most abundant plasma protein produced in adipose tissue, has been shown to be decreased in the plasma of patients with various types of cancer suggesting that adiponectin may be involved in the pathogenesis of tumor progression. In addition, studies have shown that this adipokine exhibit a suppressive effect on different types of malignancy. However, the role of adiponectin in tumor progression or tumor immunity remains unknown. In this study, we assessed the effect of adiponectin on murine breast cancer progression. We implanted murine breast cancer cells (EMT6) breast cancer cells subcutaneously into the tight flank of syngeneic mice. Local administration of adiponectin to tumor tissue decreased tumor mass in a dose-dependent manner. Since intratumoral injection of lipopolysaccharide (LPS), the major component of endotoxin, is known to inhibit tumor growth, the observed anti-tumor effect of the recombinant adiponectin might be attributable to the contamination of low amounts of bacterial endotoxin. We showed that intratumoral injection of low dose LPS failed to inhibit tumor growth and heat inactivation or protease treatment completely abrogated the cytokine’s ability to induce IL-12p35 expression in mouse bone marrow-derived dendritic cells clearly demonstrating that the observed anti-tumor effect of recombinant adiponectin is not due to LPS contamination. Our data clearly suggest that adiponectin exerts anti-tumor effects in the breast cancer model of mice via reduction of tumor-induced hematopoiesis and intratumoral injection of adiponectin may be a new strategy for the treatment of established breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schulthess T, et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/ adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 2003;278:9073–9085.

    Article  CAS  PubMed  Google Scholar 

  2. Suzuki S, Wilson-Kubalek EM, Wert D, Tsao TS, Lee DH. The oligomeric structure of high molecular weight adiponectin. FEBS Lett 2007; 581:809–814.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Waki H, Yamauchi T, Kamon J, Kita S, Ito Y, Hada Y, et al. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology 2005;146:790–796.

    Article  CAS  PubMed  Google Scholar 

  4. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002;147:173–180.

    Article  CAS  PubMed  Google Scholar 

  5. Menzaghi C, Ercolino T, Di Paola R, Berg AH, Warram JH, Scherer PE, et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002;51: 2306–2312.

    Article  CAS  PubMed  Google Scholar 

  6. Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003;14: 561–566.

    Article  CAS  PubMed  Google Scholar 

  7. Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer 2006;94:1221–1225.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Kishida K, Funahashi T, Shimomura I. Adiponectin as a routine clinical biomarker. Best Pract Res Clin Endocrinol Metab 2014;28:119–130.

    Article  CAS  PubMed  Google Scholar 

  9. Sun Y, Lodish HF. Adiponectin deficiency promotes tumor growth in mice by reducing macrophage infiltration. PLoS One 2010;5:e11987.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Lam JB, Chow KH, Xu A, Lam KS, Liu J, Wong NS, et al. Adiponectin haploinsufficiency promotes mammary tumor development in MMTVPyVT mice by modulation of phosphatase and tensin homolog activities. PLoS One 2009;4:e4968.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Nishihara T, Baba M, Matsuda M, Inoue M, Nishizawa Y, Fukuhara A, et al. Adiponectin deficiency enhances colorectal carcinogenesis and liver tumor formation induced by azoxymethane in mice. World J Gastroenterol 2008;14:6473–6480.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Fujisawa T, Endo H, Tomimoto A, Sugiyama M, Takahashi H, Saito S, et al. Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut 2008;57:1531–1538.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. Grossmann ME, Cleary MP. The balance between leptin and adiponectin in the control of carcinogenesis-focus on mammary tumorigenesis. Biochimie 2012;94:2164–2171.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Saxena A, Chumanevich A, Fletcher E, Larsen B, Lattwein K, Kaur K, et al. Adiponectin deficiency: role in chronic inflammation induced colon cancer. Biochim Biophys Acta 2012;1822:527–536.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H. Plasma adiponectin and gastric cancer. Clin Cancer Res 2005;11(2 Pt 1):466–472.

    Article  CAS  PubMed  Google Scholar 

  16. Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S. Prostate cancer and adiponectin. Urology 2005;65:1168–1172.

    Article  PubMed  Google Scholar 

  17. Spyridopoulos TN, Petridou ET, Skalkidou A, Dessypris N, Chrousos GP, Mantzoros CS, et al. Low adiponectin levels are associated with renal cell carcinoma: a case-control study. Int J Cancer 2007;120:1573–1578.

    Article  CAS  PubMed  Google Scholar 

  18. Avcu F, Ural AU, Yilmaz MI, Bingol N, Nevruz O, Caglar K. Association of plasma adiponectin concentrations with chronic lymphocytic leukemia and myeloproliferative diseases. Int J Hematol 2006;83:254–258.

    Article  PubMed  Google Scholar 

  19. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005;97:1688–1694.

    Article  CAS  PubMed  Google Scholar 

  20. Miyoshi Y, Funahashi T, Kihara S, Taguchi T, Tamaki Y, Matsuzawa Y, et al. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res 2003;9:5699–5704.

    CAS  PubMed  Google Scholar 

  21. Mantzoros C, Petridou E, Dessypris N, Chavelas C, Dalamaga M, Alexe DM, et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab 2004;89:1102–1107.

    Article  CAS  PubMed  Google Scholar 

  22. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 2004;5:153–165.

    Article  CAS  PubMed  Google Scholar 

  23. Ishikawa M, Kitayama J, Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 2004; 10:4325–4331.

    Article  CAS  PubMed  Google Scholar 

  24. Kang JH, Yu BY, Youn DS. Relationship of serum adiponectin and resistin levels with breast cancer risk. J Korean Med Sci 2007;22:117–121.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Garofalo C, Koda M, Cascio S, Sulkowska M, Kanczuga-Koda L, Golaszewska J, et al. Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res 2006;12:1447–1453.

    Article  CAS  PubMed  Google Scholar 

  26. Kang JH, Lee YY, Yu BY, Yang BS, Cho KH, Yoon DK, et al. Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch Pharm Res 2005;28:1263–1269.

    Article  CAS  PubMed  Google Scholar 

  27. Grossmann ME, Nkhata KJ, Mizuno NK, Ray A, Cleary MP. Effects of adiponectin on breast cancer cell growth and signaling. Br J Cancer 2008;98:370–379.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Nepal S, Park PH. Regulatory role of autophagy in globular adiponectininduced apoptosis in cancer cells. Biomol Ther (Seoul) 2014;22:384–389.

    Article  CAS  Google Scholar 

  29. Tworoger SS, Mantzoros C, Hankinson SE. Relationship of plasma adiponectin with sex hormone and insulin-like growth factor levels. Obesity (Silver Spring) 2007;15:2217–2224.

    Article  CAS  Google Scholar 

  30. Morad V, Abrahamsson A, Dabrosin C. Estradiol affects extracellular leptin:adiponectin ratio in human breast tissue in vivo. J Clin Endocrinol Metab 2014;99:3460–3467.

    Article  CAS  PubMed  Google Scholar 

  31. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000;102:1296–1301.

    Article  CAS  PubMed  Google Scholar 

  32. Tomizawa A, Hattori Y, Kasai K, Nakano Y. Adiponectin induces NFkappaB activation that leads to suppression of cytokine-induced NFkappaB activation in vascular endothelial cells: globular adiponectin vs. high molecular weight adiponectin. Diab Vasc Dis Res 2008;5:123–127.

    Article  PubMed  Google Scholar 

  33. Zhang P, Wang Y, Fan Y, Tang Z, Wang N. Overexpression of adiponectin receptors potentiates the antiinflammatory action of subeffective dose of globular adiponectin in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2009;29:67–74.

    Article  PubMed  Google Scholar 

  34. Rovin BH, Song H. Chemokine induction by the adipocyte-derived cytokine adiponectin. Clin Immunol 2006;120:99–105.

    Article  CAS  PubMed  Google Scholar 

  35. Haugen F, Drevon CA. Activation of nuclear factor-kappaB by high molecular weight and globular adiponectin. Endocrinology 2007;148:5478–5486.

    Article  CAS  PubMed  Google Scholar 

  36. Jung MY, Kim HS, Hong HJ, Youn BS, Kim TS. Adiponectin induces dendritic cell activation via PLC?/JNK/NF-?B pathways, leading to Th1 and Th17 polarization. J Immunol 2012;188:2592–2601.

    Article  CAS  PubMed  Google Scholar 

  37. Bråkenhielm E, Veitonmäki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, et al. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci U S A 2004;101:2476–2481.

    Article  PubMed Central  PubMed  Google Scholar 

  38. Wang Y, Lam KS, Xu JY, Lu G, Xu LY, Cooper GJ, et al. Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 2005;280:18341–18347.

    Article  CAS  PubMed  Google Scholar 

  39. Bulut Y, Michelsen KS, Hayrapetian L, Naiki Y, Spallek R, Singh M, et al. Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals. J Biol Chem 2005;280:20961–20967.

    Article  CAS  PubMed  Google Scholar 

  40. Arditi JD, Venihaki M, Karalis KP, Chrousos GP. Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm Metab Res 2007;39:9–13.

    Article  CAS  PubMed  Google Scholar 

  41. Maito FLDM, de Souza APD, Pereira L, Smithey M, Hinrichs D, Bouwer A. Intratumoral TLR-4 agonist injection is critical for modulation of tumor microenvironment and tumor rejection. ISRN Immunol 2012 [Epub]. http://dx.doi.org/10.5402/2012/926817.

    Google Scholar 

  42. Grauer OM, Molling JW, Bennink E, Toonen LW, Sutmuller RP, Nierkens S, et al. TLR ligands in the local treatment of established intracerebral murine gliomas. J Immunol 2008;181:6720–6729.

    Article  CAS  PubMed  Google Scholar 

  43. Wang RF, Miyahara Y, Wang HY. Toll-like receptors and immune regulation: implications for cancer therapy. Oncogene 2008;27:181–189.

    Article  PubMed  Google Scholar 

  44. Dieudonne MN, Bussiere M, Dos Santos E, Leneveu MC, Giudicelli Y, Pecquery R. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem Biophys Res Commun 2006;345:271–279.

    Article  CAS  PubMed  Google Scholar 

  45. Ishikawa M, Kitayama J, Yamauchi T, Kadowaki T, Maki T, Miyato H, et al. Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2. Cancer Sci 2007;98:1120–1127.

    Article  CAS  PubMed  Google Scholar 

  46. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 2000;96:1723–1732.

    CAS  PubMed  Google Scholar 

  47. Bub JD, Miyazaki T, Iwamoto Y. Adiponectin as a growth inhibitor in prostate cancer cells. Biochem Biophys Res Commun 2006;340:1158–1166.

    Article  CAS  PubMed  Google Scholar 

  48. Kato M, Watabe K, Tsujii M, Funahashi T, Shimomura I, Takehara T. Adiponectin inhibits murine pancreatic cancer growth. Dig Dis Sci 2014;59:1192–1196.

    Article  CAS  PubMed  Google Scholar 

  49. Kim AY, Lee YS, Kim KH, Lee JH, Lee HK, Jang SH, et al. Adiponectin represses colon cancer cell proliferation via AdipoR1-and-R2-mediated AMPK activation. Mol Endocrinol 2010;24:1441–1452.

    Article  CAS  PubMed  Google Scholar 

  50. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005;26:439–451.

    Article  CAS  PubMed  Google Scholar 

  51. Chen X, Wang Y. Adiponectin and breast cancer. Med Oncol 2011;28: 1288–1295.

    Article  CAS  PubMed  Google Scholar 

  52. Bausinger H, Lipsker D, Ziylan U, Manié S, Briand JP, Cazenave JP, et al. Endotoxin-free heat-shock protein 70 fails to induce APC activation. Eur J Immunol 2002;32:3708–3713.

    Article  CAS  PubMed  Google Scholar 

  53. Gao B, Tsan MF. Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J Biol Chem 2003;278:174–179.

    Article  CAS  PubMed  Google Scholar 

  54. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002;109:625–637.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  55. McAllister SS, Weinberg RA. Tumor-host interactions: a far-reaching relationship. J Clin Oncol 2010;28:4022–4028.

    Article  PubMed  Google Scholar 

  56. Ishikawa M, Hosokawa M, Oh-hara N, Niho Y, Kobayashi H. Marked granulocytosis in C57BL/6 mice bearing a transplanted BMT-11 fibrosarcoma. J Natl Cancer Inst 1987;78:567–571.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine, Catholic Kwandong University College of Medicine, International St. Mary’s Hospital, Incheon, Korea

    Sun-Hyun Kim

  2. Institute for BioMedical Convergence, Catholic Kwandong University, International St. Mary’s Hospital, Incheon, Korea

    Seong-Mi Choi & Han-Soo Kim

  3. Biomedical Research Center, Ulsan University Hospital, University of Ulsan, Ulsan, Korea

    Byung-Soo Youn

Authors
  1. Sun-Hyun Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seong-Mi Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Byung-Soo Youn
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Han-Soo Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Byung-Soo Youn or Han-Soo Kim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kim, SH., Choi, SM., Youn, BS. et al. Adiponectin inhibits mouse mammary tumor growth and reduced tumor-induced hematopoiesis. Tissue Eng Regen Med 12, 324–330 (2015). https://doi.org/10.1007/s13770-015-0019-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13770-015-0019-1

Keywords

Search

Navigation